Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland Zahn

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Vaccines|August 26, 2022
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response LevelsMachteld M Tiemessen, Laura Solforosi, Liesbeth Dekking, et al.
Plos One|August 25, 2018
Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challengeFreek Cox, Leslie van der Fits, Peter Abbink, et al.
Vaccines|January 8, 2025
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine CandidateMaarten Swart, Jessica Allen, Brendan Reed, et al.
Vaccine|June 20, 2018
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responsesMarija Vujadinovic, Selina Khan, Koen Oosterhuis, et al.
Vaccines|March 30, 2023
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical ModelsFreek Cox, Eirikur Saeland, Anne Thoma, et al.
Vaccines|January 24, 2025
Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITTLuisa Müller, Venkata A S Dabbiru, Lucy Rutten, et al.
NPJ Vaccines|May 23, 2026
Heterologous vaccination with a next-generation vaccinia virus and Ad26 induces Ebola-specific immunity in macaquesAneesh Vijayan, Tamara Cooper, Marijn van der Neut Kolfschoten, et al.
NPJ Vaccines|November 25, 2024
Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challengeLeslie van der Fits, Rineke de Jong, Karin Dijkman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 13, 2023
Economic impact of reducing treatment gaps in depressionPaul McCrone, Allan H Young, Roland Zahn, et al.
Clinical & Translational Immunology|April 22, 2026
An Ad26-MVA-BN-based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infectionsSelina Khan, Satish Boedhoe, Miranda Baert, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Vaccines|August 26, 2022
Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response LevelsMachteld M Tiemessen, Laura Solforosi, Liesbeth Dekking, et al.
Plos One|August 25, 2018
Adenoviral vector type 26 encoding Zika virus (ZIKV) M-Env antigen induces humoral and cellular immune responses and protects mice and nonhuman primates against ZIKV challengeFreek Cox, Leslie van der Fits, Peter Abbink, et al.
Vaccines|January 8, 2025
Plant Cell Culture-Derived Saponin Adjuvant Enhances Immune Response Against a Stabilized Human Metapneumovirus Pre-Fusion Vaccine CandidateMaarten Swart, Jessica Allen, Brendan Reed, et al.
Vaccine|June 20, 2018
Adenovirus based HPV L2 vaccine induces broad cross-reactive humoral immune responsesMarija Vujadinovic, Selina Khan, Koen Oosterhuis, et al.
Vaccines|March 30, 2023
RSV A2-Based Prefusion F Vaccine Candidates Induce RSV A and RSV B Cross Binding and Neutralizing Antibodies and Provide Protection against RSV A and RSV B Challenge in Preclinical ModelsFreek Cox, Eirikur Saeland, Anne Thoma, et al.
Vaccines|January 24, 2025
Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITTLuisa Müller, Venkata A S Dabbiru, Lucy Rutten, et al.
NPJ Vaccines|May 23, 2026
Heterologous vaccination with a next-generation vaccinia virus and Ad26 induces Ebola-specific immunity in macaquesAneesh Vijayan, Tamara Cooper, Marijn van der Neut Kolfschoten, et al.
NPJ Vaccines|November 25, 2024
Ad26.RSV.preF completely protects calves from severe respiratory disease induced by bovine RSV challengeLeslie van der Fits, Rineke de Jong, Karin Dijkman, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|June 13, 2023
Economic impact of reducing treatment gaps in depressionPaul McCrone, Allan H Young, Roland Zahn, et al.
Clinical & Translational Immunology|April 22, 2026
An Ad26-MVA-BN-based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infectionsSelina Khan, Satish Boedhoe, Miranda Baert, et al.
Pageof 16